8OM6 image
Deposition Date 2023-03-31
Release Date 2024-03-06
Last Version Date 2025-03-19
Entry Detail
PDB ID:
8OM6
Keywords:
Title:
Crystal structure of FGF2-STAB, a stable variant of human fibroblast growth factor 2
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.31 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Fibroblast growth factor 2
Gene (Uniprot):FGF2
Chain IDs:A
Chain Length:175
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural analysis of the stable form of fibroblast growth factor 2 - FGF2-STAB.
J Struct Biol X 10 100112 100112 (2024)
PMID: 39512606 DOI: 10.1016/j.yjsbx.2024.100112

Abstact

Fibroblast growth factor 2 (FGF2) is a signaling protein that plays a significant role in tissue development and repair. FGF2 binds to fibroblast growth factor receptors (FGFRs) alongside its co-factor heparin, which protects FGF2 from degradation. The binding between FGF2 and FGFRs induces intracellular signaling pathways such as RAS-MAPK, PI3K-AKT, and STAT. FGF2 has strong potential for application in cell culturing, wound healing, and cosmetics but the potential is severely limited by its low protein stability. The thermostable variant FGF2-STAB was constructed by computer-assisted protein engineering to overcome the natural limitation of FGF2. Previously reported characterization of FGF2-STAB revealed an enhanced ability to induce MAP/ERK signaling while having a lower dependence on heparin when compared with FGF2-wt. Here we report the crystal structure of FGF2-STAB solved at 1.3 Å resolution. Protein stabilization is achieved by newly formed hydrophobic interactions, polar contacts, and one additional hydrogen bond. The overall structure of FGF2-STAB is similar to FGF2-wt and does not reveal information on the experimentally observed lower dependence on heparin. A noticeable difference in flexibility in the receptor binding region can explain the differences in signaling between FGF2-STAB and its wild-type counterpart. Our structural analysis provided molecular insights into the stabilization and unique biological properties of FGF2-STAB.

Legend

Protein

Chemical

Disease

Primary Citation of related structures